TCIM
SYRS

TIAA CREF Investment Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

TIAA CREF Investment Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$363K Sell
2018
Q4 		$222K Sell
2018
Q3 		$483K Sell
2018
Q2 		$652K Buy
2018
Q1 		$508K Buy
2017
Q4 		$296K Sell
2017
Q3 		$471K Sell
2017
Q2 		$553K Buy
2017
Q1 		$73K Hold
2016
Q4 		$56K Buy